CN112933034A - Eye repair and nursing composition capable of removing dark circles, essence emulsion and preparation method - Google Patents
Eye repair and nursing composition capable of removing dark circles, essence emulsion and preparation method Download PDFInfo
- Publication number
- CN112933034A CN112933034A CN202110239115.6A CN202110239115A CN112933034A CN 112933034 A CN112933034 A CN 112933034A CN 202110239115 A CN202110239115 A CN 202110239115A CN 112933034 A CN112933034 A CN 112933034A
- Authority
- CN
- China
- Prior art keywords
- parts
- eye
- extract
- dark circles
- repair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 230000008439 repair process Effects 0.000 title claims abstract description 37
- 230000000474 nursing effect Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000000839 emulsion Substances 0.000 title abstract description 4
- 238000004945 emulsification Methods 0.000 title description 2
- 239000000047 product Substances 0.000 claims abstract description 51
- 239000000284 extract Substances 0.000 claims abstract description 40
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000002673 Dioscorea communis Nutrition 0.000 claims abstract description 22
- 241000544230 Dioscorea communis Species 0.000 claims abstract description 22
- 208000035753 Periorbital contusion Diseases 0.000 claims abstract description 22
- 241000186660 Lactobacillus Species 0.000 claims abstract description 20
- 238000000855 fermentation Methods 0.000 claims abstract description 20
- 230000004151 fermentation Effects 0.000 claims abstract description 20
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 20
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 229920000669 heparin Polymers 0.000 claims abstract description 16
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims abstract description 16
- 229960001008 heparin sodium Drugs 0.000 claims abstract description 16
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960001948 caffeine Drugs 0.000 claims abstract description 15
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229930182490 saponin Natural products 0.000 claims abstract description 15
- 150000007949 saponins Chemical class 0.000 claims abstract description 15
- 241000199919 Phaeophyceae Species 0.000 claims abstract description 14
- 150000004676 glycans Chemical class 0.000 claims abstract description 14
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 14
- 239000005017 polysaccharide Substances 0.000 claims abstract description 14
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 14
- 235000013353 coffee beverage Nutrition 0.000 claims abstract description 13
- 239000001599 crocus sativus l. flower extract Substances 0.000 claims abstract description 13
- 235000013336 milk Nutrition 0.000 claims abstract description 13
- 210000004080 milk Anatomy 0.000 claims abstract description 13
- 229940076591 saffron extract Drugs 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000008267 milk Substances 0.000 claims abstract description 12
- 239000003974 emollient agent Substances 0.000 claims abstract description 10
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 10
- 229940107131 ginseng root Drugs 0.000 claims abstract description 10
- 239000003755 preservative agent Substances 0.000 claims abstract description 10
- 230000002335 preservative effect Effects 0.000 claims abstract description 10
- 239000000706 filtrate Substances 0.000 claims abstract description 9
- 240000007154 Coffea arabica Species 0.000 claims abstract description 8
- 241000219784 Sophora Species 0.000 claims abstract description 8
- 241000167550 Centella Species 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 7
- 241001093951 Ailanthus altissima Species 0.000 claims abstract description 6
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 5
- 239000003906 humectant Substances 0.000 claims abstract description 5
- 239000006166 lysate Substances 0.000 claims abstract description 5
- 239000000419 plant extract Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims description 18
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 13
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 12
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 10
- 229940059958 centella asiatica extract Drugs 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- -1 polydimethylsiloxane Polymers 0.000 claims description 9
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 229920006037 cross link polymer Polymers 0.000 claims description 3
- 229920001427 mPEG Polymers 0.000 claims description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 abstract description 8
- 230000037303 wrinkles Effects 0.000 abstract description 7
- 238000011161 development Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 19
- 235000017709 saponins Nutrition 0.000 description 12
- 241000723377 Coffea Species 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 241001517197 Cattleya Species 0.000 description 6
- 244000146462 Centella asiatica Species 0.000 description 6
- 235000004032 Centella asiatica Nutrition 0.000 description 6
- 241000233855 Orchidaceae Species 0.000 description 6
- 235000007460 Coffea arabica Nutrition 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 244000124209 Crocus sativus Species 0.000 description 4
- 235000015655 Crocus sativus Nutrition 0.000 description 4
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 description 4
- 229940033280 alpha-arbutin Drugs 0.000 description 4
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 4
- 229940022757 asiaticoside Drugs 0.000 description 4
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229940072008 glycyrrhiza glabra extract Drugs 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000013974 saffron Nutrition 0.000 description 4
- 239000004248 saffron Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 241000208173 Apiaceae Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241001107098 Rubiaceae Species 0.000 description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920005573 silicon-containing polymer Polymers 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- ROTFCACGLKOUGI-JYJNAYRXSA-N (2s)-2-[[(2s)-2-[[(2s)-2-(3-acetamidopropanoylamino)-3-(1h-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1h-imidazol-5-yl)propanoic acid Chemical compound C([C@H](NC(=O)CCNC(=O)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 ROTFCACGLKOUGI-JYJNAYRXSA-N 0.000 description 1
- 241000157280 Aesculus hippocastanum Species 0.000 description 1
- 241001093963 Ailanthus Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 240000003826 Eichhornia crassipes Species 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- 241000234269 Liliales Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 241000371027 Poecilobdella Species 0.000 description 1
- 244000014047 Polianthes tuberosa Species 0.000 description 1
- 235000016067 Polianthes tuberosa Nutrition 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 241000220221 Rosales Species 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000015116 cappuccino Nutrition 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940011399 escin Drugs 0.000 description 1
- 229930186222 escin Natural products 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940045809 horse chestnut seed Drugs 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an eye repair and nursing composition capable of removing dark circles, essence milk and a preparation method of the eye repair and nursing composition. The composition comprises the following components in parts by weight: 0.01 to 20 parts of centella extract, 0.01 to 20 parts of small fruit coffee extract, 0.01 to 20 parts of brown algae polysaccharide, 0.01 to 20 parts of heptaphyllum saponin, 0.01 to 20 parts of caffeine, 0.01 to 20 parts of heparin sodium, 0.01 to 20 parts of lactobacillus fermentation lysate, 0.01 to 20 parts of sophora fruit extract, 0.01 to 20 parts of oldenlandia diffusa extract, 0.01 to 20 parts of lactobacillus and ginseng root fermentation product filtrate, 0.01 to 20 parts of saffron extract, 0.01 to 20 parts of lactobacillus and ailanthus altissima fermentation product and 0.01 to 20 parts of orchidae plant extract. The essence milk comprises the following components in parts by weight: 0.1-20 parts of eye repairing and nursing composition capable of removing dark circles, 10-20 parts of emollient, 1-3 parts of thickening agent, 1-10 parts of humectant, 0.1-1 part of preservative, 1-3 parts of emulsifier and 53-87 parts of water. The prepared essence emulsion product has excellent black eye circle removing, wrinkle and pouch removing and eye skin repairing and nursing effects, is suitable for popularization in the field of cosmetics, and has wide development prospect.
Description
Technical Field
The invention relates to the field of cosmetics, and particularly relates to an eye repair and care composition capable of removing dark circles, essence emulsion and a preparation method of the eye repair and care composition.
Background
Eyes are always called as soul windows, and the skin of eyes is much thinner than the skin of other parts of the face and is more easily damaged by the outside, so the aging is reflected in the eyes more. The ocular sub-skin is rich in connective tissue, with a very rich distribution of capillaries and nerve endings in the fibrous structure. The walls of these capillaries are very thin and permeable, so that connective tissues are easily engorged with blood and water to form hematomas and edema. The skin around the eyes is very thin and very easily dries out of water, resulting in the skin around the eyes being easily wrinkled.
The reasons for the formation of dark circles are many, for example: 1. the eyelid can not rest due to insufficient sleep and staying up all night, blood vessels around the eyes continuously tense and contract, blood flow is increased for a long time, blood stasis and edema of the blood vessels of the subcutaneous tissues of the eye circles are caused, and dark shadows are remained. 2. Inflammation, atopy or allergic contact dermatitis, and dark circles around the eye sockets. 3. The weak subcutaneous tissue around the eye is easy to cause pigmentation and is easy to be exposed on the upper and lower eyelids to form a layer of black circle. 4. Other, for example, overuse of cosmetics, smoking, aging, irregular menstruation and certain liver or kidney diseases may develop dark circles.
The black eye types are divided into four types: the first is a black eye of the melanin type, which is characterized by a tan color with pigmentary abnormalities, primarily due to pigmentation of the eye caused by an insufficiency of melanin production or metabolism. The older the person, the thinner the subcutaneous fat around the eye becomes, so the more visible the dark circles. The second is a blood vessel type black eye ring which is characterized by showing blue, pink and purple color with swelling around the eyes, mainly because of frequent staying up all night, lack of sleep, unstable emotion, eye fatigue and aging, too slow blood flow of the vein blood vessel, insufficient oxygen supply of red blood cells of the skin of the eyes, excessive accumulation of carbon dioxide and metabolic waste in the vein blood vessel, formation of chronic hypoxia, darker blood and retention and pigmentation of the eyes. The third is a structured black eye characterized by a shadow color with bags under the orbit/on the eyelids, prominent infraorbital grooves, drooping eyelids, bony prominences due to loss of fat or cartilage tissue. The fourth type is a mixed type black eye, which is the case that the three types of black eyes exist simultaneously in 2-3 types.
Therefore, products for black eye repair and eye care in cosmetics are increasingly on the market in recent years, but the increasing number of black eye symptoms also brings more requirements for eye repair care products.
However, in the process of implementing the technical solution of the invention in the embodiment of the present application, the inventor of the present application finds that at least the following technical problems exist in the prior art:
prior art (CN201710163719.0) discloses an eye care composition; the composition prepared from tuberose extract, European horse chestnut seed extract, coffee cherry extract, sodium tocopheryl phosphate and acetyl tetrapeptide-5 can re-stimulate the blood circulation system of the skin aiming at the problems of black eye circles, under-eye bags and wrinkles of eyes so as to restore the original shape and skin color of the eye contour. However, in order to achieve higher ocular repair and care effects and to accommodate more complicated and variable ocular skin conditions, further optimization and enrichment of the relevant formulations are required.
Therefore, it is a significant work to research a composition and related products which have abundant repairing and nursing functions and can adapt to various eye skin conditions.
Disclosure of Invention
In order to solve the problems, the invention provides an eye repair and care composition capable of removing dark circles, which comprises the following raw materials in parts by weight: 0.01 to 20 parts of centella extract, 0.01 to 20 parts of small fruit coffee extract, 0.01 to 20 parts of brown algae polysaccharide, 0.01 to 20 parts of heptaphyllum saponin, 0.01 to 20 parts of caffeine, 0.01 to 20 parts of heparin sodium, 0.01 to 20 parts of lactobacillus fermentation lysate, 0.01 to 20 parts of sophora fruit extract, 0.01 to 20 parts of oldenlandia diffusa extract, 0.01 to 20 parts of lactobacillus and ginseng root fermentation product filtrate, 0.01 to 20 parts of saffron extract, 0.01 to 20 parts of lactobacillus and ailanthus altissima fermentation product and 0.01 to 20 parts of orchidae plant extract.
Preferably, the weight ratio of the centella asiatica extract to the heparin sodium is 1-2: 1 to 3.
As a preferable scheme, the weight ratio of the brown algae polysaccharide to the heptaphyllum saponins to the caffeine is 2-3: 1-3: 1.
preferably, the weight ratio of the small fruit coffee extract to the saffron extract is 1-2: 3.
the invention provides a serum containing the eye repair and care composition for removing dark circles, which comprises the following raw materials in parts by weight: 0.1-20 parts of eye repairing and nursing composition capable of removing dark circles, 10-20 parts of emollient, 1-3 parts of thickening agent, 1-10 parts of humectant, 0.1-1 part of preservative, 1-3 parts of emulsifier and 53-87 parts of water.
In a preferred embodiment, the emollient is at least one of cyclopentadimethylsiloxane, dimethicone/vinyl dimethicone crosspolymer, caprylic/capric triglyceride.
As a preferred scheme, the thickening agent is at least one of xanthan gum and lecithin.
As a preferable scheme, the emulsifier is at least one of bis-PEG/PPG-20/5 PEG/PPG-20/5 polydimethylsiloxane and methoxy PEG/PPG-25/4 polydimethylsiloxane.
As a preferable scheme, the preservative is at least one of 1, 2-hexanediol and p-hydroxyacetophenone.
The invention provides a preparation method of essence milk containing the eye repair and care composition capable of removing dark circles, which comprises the following steps: (1) adding the emollient and the emulsifier into a proper container, and uniformly stirring and dispersing; (2) heating the preservative to 80 ℃, dissolving and dispersing uniformly, adding the rest raw materials into another container, adding deionized water, homogenizing and mixing uniformly; (3) and (3) uniformly mixing the components (1) and adding the mixture into the container (2), and uniformly stirring and mixing to obtain a finished product.
Has the advantages that: the invention discloses an eye repair and nursing composition capable of removing dark circles, essence milk and a preparation method thereof; the self-efficacy of each efficacy substance is greatly improved by compounding the centella extract and the heparin sodium, compounding the small fruit coffee extract and the saffron extract in the preparation raw materials and the like, so that excellent performances of diminishing inflammation, removing swelling, promoting blood circulation, removing blood stasis, removing melanin and the like are obtained.
Detailed Description
The disclosure may be understood more readily by reference to the following detailed description of preferred embodiments of the invention and the examples included therein. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the present specification, including definitions, will control.
The term "prepared from …" as used herein is synonymous with "comprising". The terms "comprises," "comprising," "includes," "including," "has," "having," "contains," "containing," or any other variation thereof, as used herein, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.
The conjunction "consisting of …" excludes any unspecified elements, steps or components. If used in a claim, the phrase is intended to claim as closed, meaning that it does not contain materials other than those described, except for the conventional impurities associated therewith. When the phrase "consisting of …" appears in a clause of the subject matter of the claims rather than immediately after the subject matter, it defines only the elements described in the clause; other elements are not excluded from the claims as a whole.
When an amount, concentration, or other value or parameter is expressed as a range, preferred range, or as a range of upper preferable values and lower preferable values, this is to be understood as specifically disclosing all ranges formed from any pair of any upper range limit or preferred value and any lower range limit or preferred value, regardless of whether ranges are separately disclosed. For example, when a range of "1 to 5" is disclosed, the described range should be interpreted to include the ranges "1 to 4", "1 to 3", "1 to 2 and 4 to 5", "1 to 3 and 5", and the like. When a range of values is described herein, unless otherwise stated, the range is intended to include the endpoints thereof and all integers and fractions within the range.
The singular forms "a", "an" and "the" include plural referents unless the context clearly dictates otherwise. "optional" or "any" means that the subsequently described event or events may or may not occur, and that the description includes instances where the event occurs and instances where it does not.
Approximating language, as used herein throughout the specification and claims, is intended to modify a quantity, such that the invention is not limited to the specific quantity, but includes portions that are literally received for modification without substantial change in the basic function to which the invention is related. Accordingly, the use of "about" to modify a numerical value means that the invention is not limited to the precise value. In some instances, the approximating language may correspond to the precision of an instrument for measuring the value. In the present description and claims, range limitations may be combined and/or interchanged, including all sub-ranges contained therein if not otherwise stated.
In addition, the indefinite articles "a" and "an" preceding an element or component of the invention are not intended to limit the number requirement (i.e., the number of occurrences) of the element or component. Thus, "a" or "an" should be read to include one or at least one, and the singular form of an element or component also includes the plural unless the stated number clearly indicates that the singular form is intended.
In order to solve the problems, the invention provides an eye repair and care composition capable of removing dark circles, which comprises the following raw materials in parts by weight: 0.01 to 20 parts of centella extract, 0.01 to 20 parts of small fruit coffee extract, 0.01 to 20 parts of brown algae polysaccharide, 0.01 to 20 parts of heptaphyllum saponin, 0.01 to 20 parts of caffeine, 0.01 to 20 parts of heparin sodium, 0.01 to 20 parts of lactobacillus fermentation lysate, 0.01 to 20 parts of sophora fruit extract, 0.01 to 20 parts of oldenlandia diffusa extract, 0.01 to 20 parts of lactobacillus and ginseng root fermentation product filtrate, 0.01 to 20 parts of saffron extract, 0.01 to 20 parts of lactobacillus and ailanthus altissima fermentation product and 0.01 to 20 parts of orchidae plant extract.
Centella asiatica: centella asiatica is a perennial herb of centella asiatica of Umbelliferae, and has creeping, slender and fibrous roots. Is distributed in Shaanxi, Jiangsu, Anhui, Zhejiang, Jiangxi provinces and the like in China, and is a lawn plant with excellent comprehensive performance. Centella asiatica is used as a medicine by using the whole herb. Is cold in nature, bitter and pungent in taste, and has the effects of clearing heat, promoting diuresis, detoxifying and reducing swelling, so that the centella asiatica extract is an excellent raw material for medical use and daily use chemicals.
And (3) small fruit coffee: coffea arabica is a small berry plant of the order rubiales, family rubiaceae, genus coffea, the oval shape of the berry, generally containing two seeds, the so-called "coffee beans". The extract of the small fruit coffee contains caffeine, protein, fat, crude fiber, various vitamins, minerals, etc., and the proper amount of caffeine has the effects of stimulating and exciting various parts of brain, heart, blood vessel, stomach and intestine, muscle, kidney, etc., and can improve metabolism function and relieve fatigue of muscle and skin.
And (3) extraction of the sophora fruit: the sophora fruit is common fruit of plants of Rosales, Leguminosae and Sophora, is cold in nature and bitter in taste, has the effects of cooling blood and stopping bleeding, and clearing liver and improving eyesight, and the extract thereof is an important raw material in the traditional Chinese medicine industry, the pharmaceutical industry and the daily chemical industry.
Herba Hedyotidis Diffusae: the herba Hedyotidis Diffusae is annual herba Elsholtziae Blumei of Rubiales, Rubiaceae, and Erysia, has long and thin root, branch, white flower, and slightly square or flat cylindrical stem, is smooth and hairless, and has effects of relieving swelling and pain, and clearing away heat and toxic materials.
Ginseng: ginseng is a perennial herb belonging to the family Araliaceae of the order Umbelliferae, is a precious Chinese medicinal material, and is known as the king of all herbs. The ginseng root contains ginsenoside A, B, C, D, E, F, etc., multiple vitamins, multiple amino acids, etc., and can be widely used as nutritional additive in skin care cosmetics such as cream, lotion, etc. It has multiple nutrients, and has effects in improving cell activity, promoting metabolism and promoting circulation of peripheral blood vessel. Can be used in skin care products for smoothing, softening and elasticity of skin, delaying aging, and inhibiting melanin generation.
Saffron: saffron is a perennial flower of liliales, iridaceae and saffron, is a rare traditional Chinese medicinal material, has strong physiological activity, has tranquilizing, phlegm eliminating and spasm relieving effects when used as a medicine in Asia and Europe, and has the effects of promoting blood circulation and removing blood stasis when used for skin.
The ailanthus altissima: the Eichhornia Crassipes (L.) Gaertn is a plant of the order Poeciales, Poecilobdella, the family Poecies, and the order Poichaea. The lactobacillus/ailanthus fermentation product mainly acts as a skin conditioner in the skin care product and has the effects of cleaning skin, relieving pressure and keeping the skin clean and active
Extract of orchidaceae plant: the orchid family plant in the application of the invention particularly refers to cattleya, which is also called Jiadelian orchid and cattleya orchid and is a perennial epiphytic herb of cattleya in the orchid family. This is called "queen of blue" because most of the genus is gorgeous in color. The whole plant of Katelia blue can be used as medicine, and has the effects of nourishing yin, moistening lung, promoting diuresis, eliminating dampness, clearing heat and detoxicating, etc. Modern pharmacological research shows that the aromatic oil, one of the aromatic components of the cattleya hybrida, can refresh the mind, remove the stagnant qi, relieve the depression and eliminate the stuffiness, thereby achieving the effects of refreshing the mind, restoring consciousness, soothing the liver, relieving the depression, regulating qi and blood, relieving dizziness and relieving neurasthenia. Thus, the extract of Kate orchid is generally used in cosmetics for anti-inflammatory, refreshing and soothing purposes.
In some preferred embodiments, the weight ratio of the centella asiatica extract to the heparin sodium is 1-2: 1 to 3.
Compared with beneficial molecules of the centella asiatica which is a polar macromolecule, the water-soluble total asiaticoside in the centella asiatica extract can quickly permeate the skin, and has excellent absorbability; the water-soluble asiaticoside can promote blood circulation, balance skin color and promote collagen production; meanwhile, the asiaticoside can also promote the proliferation of ocular fibroblasts, so that the fractured elastic fibers are repaired, and the total asiaticoside and the heparin sodium are mixed according to the weight ratio of 1-2: 1-3, the heparin sodium prevents the aggregation of platelets, prevents prothrombin from being converted into thrombin, and restores the blood circulation of eye skin, so that an excellent action environment is further provided for centella asiatica total glycoside molecules successfully permeating into the skin, and the black eye removing and eye skin nursing and repairing capabilities of the composition are further improved.
In some preferred embodiments, the weight ratio of the brown algae polysaccharide, the escin and the caffeine is 2-3: 1-3: 1.
the brown algae polysaccharide has the effects of supporting capillary vessels, activating collagen synthesis and inhibiting elastase on eye skin, so that the function of promoting blood stasis removal of the capillary vessels of the eye skin can be provided; the heptaphyllum leaf saponin can strengthen the fragile veins under the eye skin, effectively improve the haemolysis and the extravasation of venous vessels and also has the function of eliminating oxidative free radicals; the caffeine in the composition has the effects of improving microcirculation of skin at eyes, thereby increasing water content of skin and reducing roughness of skin. When brown algae polysaccharide, heptaphyllum saponin and caffeine are added in the composition in a compounding manner, and the weight is 2-3: 1-3: 1, the three components have the important efficacy performance that the three components can be effectively matched from different skin repairing and nursing angles, and the eye skin is comprehensively improved in a bad state under the synergistic effect; the three components are compounded and added, so that the composition has a three-dimensional multi-dimensional black eye removing means for promoting blood circulation, removing blood stasis, inhibiting a blood stasis source and supplementing water.
In some preferred embodiments, the weight ratio of the extract of cappuccino to the extract of saffron is 1-2: 3.
in some preferred embodiments, the eye repair and care composition capable of removing dark circles further comprises the following raw materials in parts by weight: 0.01-20 parts of nicotinamide, 0.01-20 parts of 1-methylhydantoin-2-imide, 0.01-20 parts of glycyrrhiza glabra extract and 0.01-20 parts of alpha-arbutin.
In the application of the invention, the effect of the eye repair and care composition on various types of black eyes can be further improved by adding one or more of niacinamide, 1-methylhydantoin-2-imide, glycyrrhiza glabra extract and alpha-arbutin.
The addition of niacinamide, 1-methylhydantoin-2-imide, glycyrrhiza glabra extract and alpha-arbutin in the composition can effectively inhibit the deposition of melanin in the lower part of the eye skin and can effectively eliminate the black eye ring state caused by the deposition of melanin in the eyes.
The invention provides a serum containing the eye repair and care composition for removing dark circles, which comprises the following raw materials in parts by weight: 0.1-20 parts of eye repairing and nursing composition capable of removing dark circles, 10-20 parts of emollient, 1-3 parts of thickening agent, 1-10 parts of humectant, 0.1-1 part of preservative, 1-3 parts of emulsifier and 53-87 parts of water.
In some preferred embodiments, the emollient is at least one of cyclopentadimethylsiloxane, dimethicone/vinyl dimethicone crosspolymer, caprylic/capric triglyceride.
In some preferred embodiments, the thickener is at least one of xanthan gum, lecithin.
In some preferred embodiments, the humectant is at least one of glycerin, butylene glycol, panthenol, sodium hyaluronate, sugar.
In some preferred embodiments, the emulsifier is at least one of bis-PEG/PPG-20/5 PEG/PPG-20/5 polydimethylsiloxane, methoxy PEG/PPG-25/4 polydimethylsiloxane.
In some preferred embodiments, the preservative is at least one of 1, 2-hexanediol, p-hydroxyacetophenone.
The invention provides a preparation method of essence milk containing the eye repair and care composition capable of removing dark circles, which comprises the following steps: (1) adding the emollient and the emulsifier into a proper container, and uniformly stirring and dispersing; (2) heating the preservative to 80 ℃, dissolving and dispersing uniformly, adding the rest raw materials into another container, adding deionized water, homogenizing and mixing uniformly; (3) and (3) uniformly mixing the components (1) and adding the mixture into the container (2), and uniformly stirring and mixing to obtain a finished product.
The centella asiatica extract of the present invention may be commercially available, for example, the centella asiatica extract product available from Nanning vitamin K pharmaceutical science and technology, Inc.
The heparin sodium in the invention can be a commercially available heparin sodium product, for example, sold by Nantong Xin Yuan sausage Co.
The brown algae polysaccharide of the present invention can be commercially available, for example, brown algae polysaccharide product manufactured by Xian Tianbao Biotech Co.
The heptad-leaf saponin can be a commercially available heptad-leaf saponin product, for example, sold by Shaanxi molar biotechnology limited.
Caffeine in the present invention can be a commercially available natural caffeine product such as that sold by Anhui Red Star pharmacy, Inc.
The extract of the coffea arabica of the present invention may be commercially available, for example, the coffea arabica of the Shanxi Beibei Biotech limited company.
The saffron extract in the invention can be a product of saffron extract sold in markets, such as Shanxi Xintiandoman biotechnology, Inc.
The filtrate of the fermentation products of lactobacillus and ginseng root in the present invention can be commercially available, for example, the filtrate of the fermentation products of lactobacillus and ginseng root, which is commercially available from Zhenghe biological technology Limited, Guangzhou.
The orchidaceae plant extract of the present invention may be commercially available, for example, the cattleya extract product available from Guangzhou Poa Biotech Co., Ltd.
In the present invention, other raw materials can be obtained from commercial manufacturers without any particular limitation.
Examples
The technical solution of the present invention is described in detail by the following examples, but the scope of the present invention is not limited to all of the examples. The starting materials of the present invention are all commercially available unless otherwise specified.
Example 1
The embodiment 1 provides an eye repair and care composition capable of removing dark circles in a first aspect, and the raw materials comprise the following components in parts by weight: 5 parts of centella extract, 10 parts of small fruit coffee extract, 15 parts of brown algae polysaccharide, 10 parts of hepta-leaf saponin, 5 parts of caffeine, 5 parts of heparin sodium, 5 parts of lactobacillus fermentation lysate, 10 parts of sophora fruit extract, 10 parts of oldenlandia diffusa extract, 5 parts of lactobacillus and ginseng root fermentation product filtrate, 15 parts of saffron extract, 5 parts of lactobacillus and ailanthus altissima fermentation product and 5 parts of cattleya extract.
In a second aspect of the present invention, an essence lotion containing the eye repair and care composition for removing dark circles is provided, and the raw materials include the following components in parts by weight: 15 parts of eye repair and care composition capable of removing dark circles, 12 parts of cyclopenta dimethyl silicone polymer, 2 parts of lecithin, 5 parts of sodium hyaluronate, 0.5 part of 1, 2-hexanediol, 0.5 part of p-hydroxyacetophenone, 2 parts of bis-PEG/PPG-20/5 PEG/PPG-20/5 dimethyl silicone polymer and 65 parts of deionized water.
In a third aspect of the present embodiment, there is provided a method for preparing a serum containing the above eye repair and care composition for removing dark circles, the method includes the following steps: (1) adding 12 parts of cyclopentasiloxane and 2 parts of bis-PEG/PPG-20/5 PEG/PPG-20/5 polydimethylsiloxane into a stirring container, and uniformly stirring and dispersing; (2) heating 0.5 part of 1, 2-hexanediol and 0.5 part of p-hydroxyacetophenone to 80 ℃, dissolving and dispersing uniformly, adding 15 parts of the eye repair and care composition for removing dark circles, 2 parts of lecithin and 5 parts of sodium hyaluronate into another stirring container, adding 65 parts of deionized water, and homogenizing and mixing uniformly; (3) and (3) uniformly mixing the components (1) and adding the mixture into the container (2), and uniformly stirring and mixing to obtain a finished product.
The centella asiatica extract in this embodiment is a centella asiatica extract product sold by Nanning Weikang pharmaceutical science and technology Limited.
The heparin sodium in the embodiment is a heparin sodium product sold by Nantong Xin source sausage casing company Limited.
The brown algae polysaccharide in this embodiment is a brown algae polysaccharide product produced by sienna tianbao biotechnology limited.
The heptad leaf saponin in the embodiment is a heptad leaf saponin product sold by Shaanxi mol biotechnology limited.
The coffee in this example is a natural caffeine product sold by Anhui Red Star pharmacy Ltd.
In the embodiment, the extract of the coffea arabica is a coffea arabica extract product sold by Shanxi Yuan Beibei Biotech limited company.
The saffron extract in this example is a saffron extract product sold by the biotechnology limited of the Xintiandoma of Shaanxi.
In this embodiment, the lactobacillus and ginseng root fermentation product filtrate is a lactobacillus and ginseng root fermentation product filtrate product produced and sold by Guangzhou Zhenghe Biotech Co.
In the present example, the Katland extract is a product of Katland extract sold by Zhenghe Biotech, Guangzhou.
In this example, all other raw materials are commercially available from manufacturers without any particular limitation.
The composition obtained in this example was designated as Z1.
Example 2
The embodiment of the present invention is different from embodiment 1 in that: the centella asiatica extract may be 10 parts.
The composition obtained in this example was designated as Z2.
Example 3
The embodiment of the present invention is different from embodiment 1 in that: the seven-leaf saponin is 15 parts.
The composition obtained in this example was designated as Z3.
Example 4
The embodiment of the present invention is different from embodiment 1 in that: 5 parts of nicotinamide, 5 parts of 1-methylhydantoin-2-imide, 5 parts of glycyrrhiza glabra extract and 5 parts of alpha-arbutin are also added into the eye repair and care composition.
The composition obtained in this example was designated as Z4.
Comparative example 1
The embodiment of this comparative example is the same as example 1 except that: 1 part of centella.
The composition produced in this comparative example was designated as D1.
Comparative example 2
The embodiment of this comparative example is the same as example 1 except that: the weight portion of heparin sodium is 25 portions.
The composition produced in this comparative example was designated as D2.
Comparative example 3
The embodiment of this comparative example is the same as example 1 except that: the coffee is 15.
The composition produced in this comparative example was designated as D3.
Comparative example 4
The embodiment of this comparative example is the same as example 1 except that: the seven-leaf saponin is 25 parts.
The composition produced in this comparative example was designated as D4.
Comparative example 5
The embodiment of this comparative example is the same as example 1 except that: the saffron extract accounts for 1 part.
The composition produced in this comparative example was designated as D5.
Evaluation of Performance
1. Evaluation of the cosmetic Effect of the product: 80 product testees, namely 32 men and 48 women, are selected and divided into 8 groups, wherein each group comprises 6 women and 4 men. The age of the tested person is between 15 and 35 years.
Skin condition: the periphery of the eyes has obvious dark circles, wrinkles and pouches, has no allergic history of skin diseases, and meets the voluntary selection standard of the subject.
And (3) testing a product: examples a corresponding serum milk containing an eye repair care composition was prepared in comparative example.
The test method comprises the following steps: applying a proper amount of test samples prepared in the examples 1-3 and all the comparative examples on the cleaned affected parts around the eyes of each group of tested persons, 1 time per day, and trying for 4 weeks; subjects maintained good working and resting time and eating habits during the trial period. And after 4 weeks, counting the feedback condition of the testee, and respectively evaluating the black eye circle removing effect, wrinkle and pouch removing effect and eye skin repairing and nursing effect of the product, wherein the evaluation grades are divided into five types, namely excellent, better, common, worse and extremely poor. After 4 weeks, more than 90% of black eye disease parts of testers are completely eliminated, no obvious wrinkles and pouches are visible, and the evaluation level is excellent if the eye skin is soft and glossy; better, general, worse and extremely poor correspond to more than 80%, 60%, 40% and 20% of black eye patients after 4 weeks respectively, and the black eye patients are completely eliminated without obvious wrinkles and pouches and the eye skin is soft, moist and glossy. The specific test results are shown in table 1 below.
2. The product has the effect of removing black eye circles: 80 product testees, namely 32 men and 48 women, are selected and divided into 8 groups, wherein each group comprises 6 women and 4 men. The age of the tested person is between 15 and 35 years.
Skin condition: there were clear dark circles around the eyes and met the subject's volunteer enrollment criteria.
And (3) testing a product: the corresponding essence milks comprising the eye repair care composition prepared in examples 1 to 3 and all comparative examples.
The test method comprises the following steps: the test panelists used the essence milk products of examples and comparative examples 1 time per day for 1 month, evaluated the skin whitening effect after 4 weeks of use, and tested the L value (black and white brightness) of the skin at the dark circles, and the initial average eye dark circle L value was 55. The values measured in each group were averaged and reported in Table 1.
TABLE 1
According to the eye repair and nursing composition capable of removing black eye circles, the essence lotion and the preparation method thereof, provided by the invention, the prepared essence lotion product has excellent effects of removing black eye circles, removing wrinkle bags and repairing and nursing eye skin, is suitable for popularization in the field of cosmetics, and has a wide development prospect. Wherein, the best product effect is obtained under the conditions of the best raw material weight ratio and the like in the example 1.
Finally, it should be understood that the above-described embodiments are merely preferred embodiments of the present invention, and not intended to limit the present invention, and any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
1. The eye repair and care composition capable of removing the dark circles is characterized by comprising the following components in parts by weight: the raw materials comprise the following components in parts by weight: 0.01 to 20 parts of centella extract, 0.01 to 20 parts of small fruit coffee extract, 0.01 to 20 parts of brown algae polysaccharide, 0.01 to 20 parts of heptaphyllum saponin, 0.01 to 20 parts of caffeine, 0.01 to 20 parts of heparin sodium, 0.01 to 20 parts of lactobacillus fermentation lysate, 0.01 to 20 parts of sophora fruit extract, 0.01 to 20 parts of oldenlandia diffusa extract, 0.01 to 20 parts of lactobacillus and ginseng root fermentation product filtrate, 0.01 to 20 parts of saffron extract, 0.01 to 20 parts of lactobacillus and ailanthus altissima fermentation product and 0.01 to 20 parts of orchidae plant extract.
2. The black eye removable eye repair treatment composition according to claim 1, wherein: the weight ratio of the centella asiatica extract to the heparin sodium is 1-2: 1 to 3.
3. The black eye removable eye repair treatment composition according to claim 1, wherein: the weight ratio of the brown algae polysaccharide to the seven-leaf saponin to the caffeine is 2-3: 1-3: 1.
4. the black eye removable eye repair treatment composition according to claim 1, wherein: the weight ratio of the small fruit coffee extract to the saffron extract is 1-2: 3.
5. an essence lotion containing the eye repair and care composition for dark circles removal according to any one of claims 1 to 4, which is characterized in that: the raw materials comprise the following components in parts by weight: 0.1-20 parts of eye repairing and nursing composition capable of removing dark circles, 10-20 parts of emollient, 1-3 parts of thickening agent, 1-10 parts of humectant, 0.1-1 part of preservative, 1-3 parts of emulsifier and 53-87 parts of water.
6. The essence milk containing the eye repair and care composition for removing dark circles according to claim 5, characterized in that: the emollient is at least one of cyclopentadimethylsiloxane, polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer, and caprylic/capric triglyceride.
7. The essence milk containing the eye repair and care composition for removing dark circles according to claim 5, characterized in that: the thickener is at least one of xanthan gum and lecithin.
8. The essence milk containing the eye repair and care composition for removing dark circles according to claim 5, characterized in that: the emulsifier is at least one of bis-PEG/PPG-20/5 PEG/PPG-20/5 polydimethylsiloxane and methoxy PEG/PPG-25/4 polydimethylsiloxane.
9. The essence milk containing the eye repair and care composition for removing dark circles according to claim 5, characterized in that: the preservative is at least one of 1, 2-hexanediol and p-hydroxyacetophenone.
10. A method for preparing the essence milk containing the eye repair and care composition for removing dark circles according to any one of claims 5 to 9, which is characterized by comprising the following steps: the method comprises the following steps: (1) adding the emollient and the emulsifier into a proper container, and uniformly stirring and dispersing; (2) heating the preservative to 80 ℃, dissolving and dispersing uniformly, adding the rest raw materials into another container, adding deionized water, homogenizing and mixing uniformly; (3) and (3) uniformly mixing the components (1) and adding the mixture into the container (2), and uniformly stirring and mixing to obtain a finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110239115.6A CN112933034A (en) | 2021-03-04 | 2021-03-04 | Eye repair and nursing composition capable of removing dark circles, essence emulsion and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110239115.6A CN112933034A (en) | 2021-03-04 | 2021-03-04 | Eye repair and nursing composition capable of removing dark circles, essence emulsion and preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112933034A true CN112933034A (en) | 2021-06-11 |
Family
ID=76247554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110239115.6A Pending CN112933034A (en) | 2021-03-04 | 2021-03-04 | Eye repair and nursing composition capable of removing dark circles, essence emulsion and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112933034A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113876656A (en) * | 2021-10-29 | 2022-01-04 | 湖北省麦诗特生物科技有限公司 | Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof |
| CN113893215A (en) * | 2021-10-09 | 2022-01-07 | 广州市涵美化妆品有限公司 | Eye tightening and repairing composition, application, eye cream and preparation method thereof |
| CN115227631A (en) * | 2022-07-11 | 2022-10-25 | 中山市天图精细化工有限公司 | Anhydrous essence composition and preparation method and application thereof |
| CN115300433A (en) * | 2022-09-16 | 2022-11-08 | 湖北马应龙生物科技有限公司 | Eye mask essence with whitening and repairing effects and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107519084A (en) * | 2017-08-28 | 2017-12-29 | 清远市立道精细化工有限公司 | A kind of after-sun restorative mousse aerosol and preparation method thereof |
| CN108261368A (en) * | 2018-02-09 | 2018-07-10 | 广州重生化妆品实业有限公司 | A kind of compound goes pouch gel and its preparation process |
| CN110538099A (en) * | 2018-05-29 | 2019-12-06 | 范丽荣 | Plant-refined, condensed, moisturizing, firming, skin-refreshing and beautifying facial mask |
| CN111840144A (en) * | 2020-09-04 | 2020-10-30 | 北京最美芳华生物科技有限公司 | Moisturizing and repairing composition, skin care product and preparation method thereof |
-
2021
- 2021-03-04 CN CN202110239115.6A patent/CN112933034A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107519084A (en) * | 2017-08-28 | 2017-12-29 | 清远市立道精细化工有限公司 | A kind of after-sun restorative mousse aerosol and preparation method thereof |
| CN108261368A (en) * | 2018-02-09 | 2018-07-10 | 广州重生化妆品实业有限公司 | A kind of compound goes pouch gel and its preparation process |
| CN110538099A (en) * | 2018-05-29 | 2019-12-06 | 范丽荣 | Plant-refined, condensed, moisturizing, firming, skin-refreshing and beautifying facial mask |
| CN111840144A (en) * | 2020-09-04 | 2020-10-30 | 北京最美芳华生物科技有限公司 | Moisturizing and repairing composition, skin care product and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| JESIGN: "眼霜真的有用吗，有效成分是什么？", 《知乎》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113893215A (en) * | 2021-10-09 | 2022-01-07 | 广州市涵美化妆品有限公司 | Eye tightening and repairing composition, application, eye cream and preparation method thereof |
| CN113893215B (en) * | 2021-10-09 | 2023-08-08 | 广州市涵美化妆品有限公司 | Eye tightening and repairing composition, application and eye cream and preparation method thereof |
| CN113876656A (en) * | 2021-10-29 | 2022-01-04 | 湖北省麦诗特生物科技有限公司 | Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof |
| CN115227631A (en) * | 2022-07-11 | 2022-10-25 | 中山市天图精细化工有限公司 | Anhydrous essence composition and preparation method and application thereof |
| CN115300433A (en) * | 2022-09-16 | 2022-11-08 | 湖北马应龙生物科技有限公司 | Eye mask essence with whitening and repairing effects and preparation method and application thereof |
| CN115300433B (en) * | 2022-09-16 | 2024-02-09 | 湖北马应龙生物科技有限公司 | Eye mask essence with whitening and repairing effects and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112933034A (en) | Eye repair and nursing composition capable of removing dark circles, essence emulsion and preparation method | |
| CN109453095A (en) | A kind of niacinamide stoste and preparation method thereof | |
| CN105726391A (en) | Dendrobium-officinale shower gel | |
| CN110772454A (en) | Compound essential oil for skin brightening, moisturizing, soothing and anti-aging, and preparation method and application thereof | |
| CN107582500B (en) | Hair-blackening and hair-nourishing shampoo preparation containing moutan bark and preparation method thereof | |
| CN111956555A (en) | Herbal firming compound composition, facial mask and preparation method of facial mask | |
| CN108743501B (en) | Plant fermentation raw stock composition and application thereof | |
| KR102054793B1 (en) | Cosmetic composition Cosmetic for improving skin elasticity and reducing dark circles containing natural extract and fermented extract | |
| CN110575411A (en) | spray mask composition | |
| CN103462855B (en) | Cosmetic containing American ginseng and longan and preparation method thereof | |
| CN104814916A (en) | Moisturizing essence and preparing method thereof | |
| CN107397098A (en) | A kind of dendrobium candidum leaf drink and preparation method and application | |
| CN111870541A (en) | Herbal whitening compound composition, mask and preparation method thereof | |
| CN114010571B (en) | Natural extract for soothing skin and improving skin quality and application thereof | |
| CN113559037B (en) | Cassia seed compound collagen liposome and application thereof | |
| CN109568230A (en) | A kind of Chinese medicine cosmetic of the anti-aging of moisturizing whitening | |
| CN115006336A (en) | Plant shampoo capable of preventing hair loss, strengthening hair, removing dandruff and relieving itching and preparation method thereof | |
| CN109646359B (en) | Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof | |
| CN114159341A (en) | Freeze-dried eye patch and preparation method thereof | |
| CN113876656A (en) | Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof | |
| CN110101648B (en) | Beauty-care concealer air cushion BB cream | |
| CN111265443A (en) | Anti-aging essence skin care lotion containing codonopsis pilosula extract and preparation method of anti-aging essence skin care lotion | |
| CN106511213A (en) | Cosmetic containing plant extract liquid | |
| CN108686107B (en) | Chinese herbal medicine composition for promoting hair growth, preparation method and application thereof | |
| CN106389284A (en) | Blacking and nourishing hair mask and preparation method of blacking and nourishing hair mask |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210611 |
|
| RJ01 | Rejection of invention patent application after publication |